Rentschler Commissions 2000-L Single-Use Bioreactor
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.
Rentschler Biotechnologie, a contract manufacturing and development organization for biopharmaceuticals, announced on March 23 that the company’s 2000-L single-use bioreactor has been put into operation.
The bioreactor, built and commissioned in six months, doubles the company’s single-use manufacturing capabilities and integrates in the existing manufacturing suites by supplementing two existing 1000-L single-use bioreactors, according to a company statement.
Rentschler has more than five years’ experience with single-use bioreactors and features a facility with a flexible space concept and movable equipment.
Rentschler also announced that the company will invest €24 million to build a system with two 3,000-L stainless steel bioreactors.
Source: Rentschler Biotechnologie
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
